230 related articles for article (PubMed ID: 31053981)
1. Procedural findings and early healing response after implantation of a self-apposing bioresorbable scaffold in coronary bifurcation lesions.
Holck EN; Fox-Maule C; Barkholt TØ; Jakobsen L; Tu S; Maeng M; Dijkstra J; Christiansen EH; Holm NR
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1199-1210. PubMed ID: 31053981
[TBL] [Abstract][Full Text] [Related]
2. Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
Barkholt TØ; Neghabat O; Holck EN; Andreasen LN; Christiansen EH; Holm NR
Catheter Cardiovasc Interv; 2022 Mar; 99(4):1075-1083. PubMed ID: 34967094
[TBL] [Abstract][Full Text] [Related]
3. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
[TBL] [Abstract][Full Text] [Related]
4. Long-term invasive follow-up of bioresorbable vascular scaffold: Optical Coherence Tomography assessment of jailed side branches.
Paradies V; Smits PC; Vachojannis GJ; Royaards KJ; Wassing J; van der Ent M
Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):279-285. PubMed ID: 29066339
[TBL] [Abstract][Full Text] [Related]
5. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
Bennett J; Adriaenssens T; Desmet W; Dubois C
Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
[TBL] [Abstract][Full Text] [Related]
6. Plaque morphology predictors of side branch occlusion after provisional stenting in coronary bifurcation lesion: Results of optical coherence tomography bifurcation study (ORBID).
Kini AS; Vengrenyuk Y; Pena J; Yoshimura T; Panwar SR; Motoyama S; Kezbor S; Hasan CM; Palkhiwala S; Kovacic JC; Moreno P; Baber U; Mehran R; Narula J; Sharma SK
Catheter Cardiovasc Interv; 2017 Feb; 89(2):259-268. PubMed ID: 27029714
[TBL] [Abstract][Full Text] [Related]
7. Neointimal response to everolimus-eluting bioresorbable scaffolds implanted at bifurcating coronary segments: insights from optical coherence tomography.
Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
Int J Cardiovasc Imaging; 2017 Feb; 33(2):169-175. PubMed ID: 27757563
[TBL] [Abstract][Full Text] [Related]
8. Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Grundeken MJ; Nakatani S; Asano T; Sotomi Y; Foin N; Ng J; Okamura T; Wykrzykowska JJ; de Winter RJ; van Geuns RJ; Koolen J; Christiansen EH; Whitbourn R; McClean D; Smits P; Windecker S; Ormiston JA; Serruys PW
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28893770
[TBL] [Abstract][Full Text] [Related]
9. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
10. Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
Tanaka A; Jabbour RJ; Kawamoto H; Mangieri A; Pagnesi M; Montalto C; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A
Catheter Cardiovasc Interv; 2016 Nov; 88(6):865-870. PubMed ID: 27219102
[TBL] [Abstract][Full Text] [Related]
11. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
Tanaka A; Latib A; Kawamoto H; Jabbour RJ; Mangieri A; Pagnesi M; Montalto C; Regazzoli D; Ancona M; Chieffo A; Carlino M; Montorfano M; Colombo A
Catheter Cardiovasc Interv; 2016 Nov; 88(6):854-862. PubMed ID: 27184769
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing two stent sizing strategies in coronary bifurcation treatment with bioresorbable vascular scaffolds - The Absorb Bifurcation Coronary (ABC) trial.
Rampat R; Mayo T; Hildick-Smith D; Cockburn J
Cardiovasc Revasc Med; 2019 Jan; 20(1):43-49. PubMed ID: 30170828
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the proximal optimization technique on crossover stenting in coronary bifurcation lesions in the 3D-OCT bifurcation registry.
Murasato Y; Mori T; Okamura T; Nagoshi R; Fujimura T; Yamawaki M; Ono S; Serikawa T; Nakao F; Shite J;
Int J Cardiovasc Imaging; 2019 Jun; 35(6):981-990. PubMed ID: 30887408
[TBL] [Abstract][Full Text] [Related]
15. The Relation Between Optical Coherence Tomography-Detected Layered Pattern and Acute Side Branch Occlusion after Provisional Stenting of Coronary Bifurcation Lesions.
Cao Y; Mintz GS; Matsumura M; Zhang W; Lin Y; Wang X; Fujino A; Lee T; Murai T; Hoshino M; Usui E; Kanaji Y; Yonetsu T; Kakuta T; Maehara A
Cardiovasc Revasc Med; 2019 Nov; 20(11):1007-1013. PubMed ID: 30683562
[TBL] [Abstract][Full Text] [Related]
16. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S
JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155
[TBL] [Abstract][Full Text] [Related]
17. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162
[TBL] [Abstract][Full Text] [Related]
18. Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.
Gutiérrez-Chico JL; Cortés C; Schincariol M; Limon U; Yalcinli M; Durán-Cortés MA; Jaguszewski M
Cardiol J; 2018; 25(4):443-458. PubMed ID: 29774520
[TBL] [Abstract][Full Text] [Related]
19. Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions.
Kawamoto H; Ruparelia N; Tanaka A; Chieffo A; Latib A; Colombo A
JACC Cardiovasc Interv; 2016 May; 9(10):989-1000. PubMed ID: 27198679
[TBL] [Abstract][Full Text] [Related]
20. Neointimal coverage of jailed side branches in coronary bifurcation lesions: an optical coherence tomography analysis.
Kume T; Yamada R; Terumasa K; Tamada T; Imai K; Fukuhara K; Goryo Y; Kawamura A; Hiroshi O; Neishi Y; Uemura S
Coron Artery Dis; 2018 Mar; 29(2):114-118. PubMed ID: 28926354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
